MORGAN STANLEY - ALTAMIRA THERAPEUTICS LTD ownership

ALTAMIRA THERAPEUTICS LTD's ticker is and the CUSIP is G0360L100. A total of 16 filers reported holding ALTAMIRA THERAPEUTICS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of ALTAMIRA THERAPEUTICS LTD
ValueSharesWeighting
Q3 2022$17,000
+30.8%
58,731
+123.3%
0.00%
Q2 2022$13,000
+44.4%
26,300
+216.9%
0.00%
Q1 2022$9,000
-40.0%
8,300
+3.8%
0.00%
Q4 2021$15,000
-51.6%
8,000
-48.9%
0.00%
Q3 2021$31,00015,6480.00%
Other shareholders
ALTAMIRA THERAPEUTICS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,148$803,0000.06%
BOOTHBAY FUND MANAGEMENT, LLC 40,273$81,0000.00%
Renaissance Technologies 71,226$143,0000.00%
Stonebridge Capital Advisors LLC 100$00.00%
UBS Group AG 3,923$8,0000.00%
TWO SIGMA INVESTMENTS, LP 16,019$32,0000.00%
OSAIC HOLDINGS, INC. 1,936$4,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 8,435$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ALTAMIRA THERAPEUTICS LTD shareholders